360 High-Risk Vulnerability Immunization Tool V2.0 vs Comodo Advanced Endpoint Protection: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Comodo Advanced Endpoint Protection: Endpoint protection platform using zero trust architecture and containment. built by Comodo. Core capabilities include Auto Containment Technology for virtualizing unknown files, Host Intrusion Prevention System (HIPS), Antivirus with automatic detection and quarantine..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Comodo Advanced Endpoint Protection differentiates with Auto Containment Technology for virtualizing unknown files, Host Intrusion Prevention System (HIPS), Antivirus with automatic detection and quarantine.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Comodo Advanced Endpoint Protection is developed by Comodo. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Comodo Advanced Endpoint Protection serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.